Molecule Details
InChIKeyGMIZZEXBPRLVIV-SECBINFHSA-N
Compound NameSch-900776
Canonical SMILESCn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)6
Pfam Stratification Cross-Family
Avg pChEMBL7.14
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11899
Drug NameMK-8776
CAS Number891494-63-6
Groups investigational
ATC Codes nan
DescriptionSch 900776 has been used in trials studying the treatment of Neoplasms, Hodgkin Disease, Adult Erythroleukemia, Lymphoma, Non-Hodgkin, and Myelogenous Leukemia, Acute, among others.

Cross-references: BindingDB: 50434372 CHEMBL2386889 ChemSpider: 28424100 PubChem:46239015 PubChem:347828232 ZINC: ZINC000060328032
Target Activities (6)
Target Gene Organism Category Pfam pChEMBL Type Source
O14757 CHEK1 Homo sapiens Human PF00069 8.5 IC50 ChEMBL;BindingDB
P43686 PSMC4 Homo sapiens Human PF00004 PF17862 PF16450 8.3 Kd ChEMBL
Q32MK0 MYLK3 Homo sapiens Human PF00069 6.7 Kd ChEMBL
Q9H0K1 SIK2 Homo sapiens Human PF00069 PF23312 6.6 Kd ChEMBL
P19784 CSNK2A2 Homo sapiens Human PF00069 6.5 Kd ChEMBL
Q13163 MAP2K5 Homo sapiens Human PF00564 PF00069 6.2 Kd ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
O14757 CHEK1 Serine/threonine-protein kinase Chk1 inhibitor targets